RACHEL TAYLOR: Open Payments
NPI 1598396939 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 11 payments from 8 companies in 2025. Trend: 2023 $295 · 2024 $751 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $246 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| GENZYME CORPORATION | 1 | $122 |
| Grifols USA, LLC | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Insulet Corporation | 3 | $79 |
Products named: KRYSTEXXA, AUSTEDO XR, TZIELD, FABRAZYME, Prolastin-C Liquid, AMVUTTRA, Omnipod.
Industry payments across TX — which companies pay providers there.
